| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.37 | 0.05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |